CCM
TEVA icon

Covington Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Covington Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$18K Hold
2,275
– – ﹤0.01% 732
2022
Q2 		$17K Hold
2,275
– – ﹤0.01% 732
2022
Q1 		$21K Hold
2,275
– – ﹤0.01% 712
2021
Q4 		$18K Hold
2,275
– – ﹤0.01% 704
2021
Q3 		$22K Buy
+2,275
New +$21.3K ﹤0.01% 685
2014
Q2 		– Sell
-9,250
Closed -$489K – 255
2014
Q1 		$489K Sell
9,250
-15,170
-62% -$701K 0.05% 187
2013
Q4 		$979K Sell
24,420
-20,825
-46% -$820K 0.1% 146
2013
Q3 		$1.71M Sell
45,245
-19,304
-30% -$753K 0.2% 114
2013
Q2 		$2.53M Buy
+64,549
New +$2.51M 0.31% 93

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Covington Capital Management's TEVA Position: Q3 2022 in Review

Covington Capital Management held its Teva Pharmaceuticals (TEVA) position steady in Q3 2022 at 2,275 shares worth $18K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Covington Capital Management first reported a position in TEVA in Q2 2013 and has held it in 9 quarters since. The position peaked at $2.53M in Q2 2013. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Covington Capital Management held 2,275 shares of Teva Pharmaceuticals worth $18K as of Q3 2022.
  • Covington Capital Management left its Teva Pharmaceuticals share count unchanged in Q3 2022.
  • Teva Pharmaceuticals made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #732 holding.
  • Covington Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 9 quarters since.
  • Covington Capital Management's Teva Pharmaceuticals position peaked at $2.53M in Q2 2013.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.